Transaortic transcatheter aortic valve implantation: A novel approach for the truly "no-access option" patients

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 7, 2010, Pages 1129-1136

  Latsios, George ^a   Gerckens, Ulrich ^a   Grube, Eberhard ^a  

^a Heart Center Siegburg   (Germany)

Author keywords

Aortic stenosis; Aortic valve disease; Valve prosthesis

Indexed keywords

ACETYLSALICYLIC ACID; CEFTRIAXONE; CLOPIDOGREL; HEPARIN; PROTAMINE;

ACUTE HEART INFARCTION; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; ASCENDING AORTA; CASE REPORT; DISEASE SEVERITY; EXTUBATION; FEMALE; HOSPITAL DISCHARGE; HUMAN; IMPLANTATION; MINIMALLY INVASIVE SURGERY; MOBILIZATION; MORTALITY; OFF PUMP SURGERY; PUNCTURE; SAFETY; STERNOTOMY; STROKE; SUTURING METHOD; TRANSAORTIC TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; VASCULAR SURGERY;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; AORTOGRAPHY; BALLOON DILATATION; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; PROSTHESIS DESIGN; PUNCTURES; STERNOTOMY; SUTURE TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77952781134     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22378     Document Type: Article

References (15)

1. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:882-883.
2. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-822; discussion 822-823. (Pubitemid 29331957)
3. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850. (Pubitemid 43754305)
4. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-inman study. Circulation 2006;114:1616-1624. (Pubitemid 44547432)
5. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
6. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249.
7. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation 2006;114:591-596. (Pubitemid 44202060)
8. Gerckens U, Latsios G, Mueller R, et al. Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication. Clin Res Cardiol 2009;98:687-690.
9. Fraccaro C, Napodano M, Tarantini G, et al. Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: The III generation CoreValve revalving system. J Am Coll Cardiovasc Interv 2009;2:828-833.
10. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: Results of three device generations of the corevalve revalving system. Circ Cardiovasc Intervent 2008;1:167-175.
11. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography. Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003;108:1146-1162.
12. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;52:e1-e142.
13. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006;82:2111-2115.
14. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243. (Pubitemid 36834640)
15. Bauernschmitt R, Schreiber C, Bleiziffer S, et al. Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients. Heart Surg Forum 2009;12:E63-E64.